Thrombospondin-1 is a major activator of TGF-beta in fibrotic renal disease in the rat in vivo.
about
Functional Anatomy of the Outflow FacilitiesThrombospondin1 in tissue repair and fibrosis: TGF-β-dependent and independent mechanismsActivated CD47 regulates multiple vascular and stress responses: implications for acute kidney injury and its managementA thrombospondin-1 antagonist of transforming growth factor-beta activation blocks cardiomyopathy in rats with diabetes and elevated angiotensin IIGenes involved in TGF beta1-driven epithelial-mesenchymal transition of renal epithelial cells are topologically related in the human interactome mapPDE-5 inhibition impedes TSP-1 expression, TGF-beta activation and matrix accumulation in experimental glomerulonephritis.Correlation of enhanced thrombospondin-1 expression, TGF-beta signalling and proteinuria in human type-2 diabetic nephropathy.Thrombospondin-2 therapy ameliorates experimental glomerulonephritis via inhibition of cell proliferation, inflammation, and TGF-beta activation.Glucose downregulation of PKG-I protein mediates increased thrombospondin1-dependent TGF-{beta} activity in vascular smooth muscle cellsDifferential regulation of miRNA and mRNA expression in the myocardium of Nrf2 knockout miceThrombospondin1 deficiency reduces obesity-associated inflammation and improves insulin sensitivity in a diet-induced obese mouse model.TGF-beta receptor deletion in the renal collecting system exacerbates fibrosis.Two clinical phenotypes in polycythemia vera.Curcumin protects against lipopolysaccharide-induced vasoconstriction dysfunction via inhibition of thrombospondin-1 and transforming growth factor-β1Identification of Enolase 1 and Thrombospondin-1 as serum biomarkers in HBV hepatic fibrosis by proteomicsA 3-biomarker-panel predicts renal outcome in patients with proteinuric renal diseases.Blockade of TSP1-dependent TGF-β activity reduces renal injury and proteinuria in a murine model of diabetic nephropathy.Long-term gene therapy with thrombospondin 2 inhibits TGF-β activation, inflammation and angiogenesis in chronic allograft nephropathyThrombospondin1 deficiency attenuates obesity-associated microvascular complications in ApoE-/- miceInteraction of thrombospondin1 and CD36 contributes to obesity-associated podocytopathy.Pigment epithelium-derived factor regulates early pancreatic fibrotic responses and suppresses the profibrotic cytokine thrombospondin-1.Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action.Latent TGF-beta binding proteins: extracellular matrix association and roles in TGF-beta activation.Tracheal Aspirate Levels of the Matricellular Protein SPARC Predict Development of Bronchopulmonary DysplasiaUrinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients.Thrombospondin 1 Deficiency Ameliorates the Development of Adriamycin-Induced Proteinuric Kidney Disease.Transcriptional and Post-Transcriptional Regulation of Thrombospondin-1 Expression: A Computational Model.Actions of Huangqi decoction against rat liver fibrosis: a gene expression profiling analysis.Alcohol Differentially Alters Extracellular Matrix and Adhesion Molecule Expression in Skeletal Muscle and HeartTherapeutic potential of TGF-beta inhibition in chronic renal failure.Inflammatory properties of inhibitor of DNA binding 1 secreted by synovial fibroblasts in rheumatoid arthritis.Influence of ginsenoside Rg1, a panaxatriol saponin from Panax notoginseng, on renal fibrosis in rats with unilateral ureteral obstruction.Differential global and extra-cellular matrix focused gene expression patterns between normal and glaucomatous human lamina cribrosa cells.Thrombospondin 1 mediates renal dysfunction in a mouse model of high-fat diet-induced obesity.Vascular consequences of dietary salt intake.TGF-beta signal transduction in chronic kidney diseaseThe Role of Clinical Proteomics, Lipidomics, and Genomics in the Diagnosis of Alzheimer's Disease.Thrombospondins: old players, new gamesInvoking the power of thrombospondins: regulation of thrombospondins expressionIdentification of thrombospondin 1 (TSP-1) as a novel mediator of cell injury in kidney ischemia.
P2860
Q26785741-ADDC53CB-7CD5-411F-8346-E4F940FC1B7DQ26823508-6411018F-94DB-4281-9BC9-E82BA8C2EF26Q26864499-84C8B3CC-0C5D-438A-8F12-E59DFCD1A1EBQ28583200-0F40BEBC-71AD-4801-9D53-52610DFA5894Q33303477-1509B048-7055-425A-BECE-D662E30ED25CQ33348441-84CE139B-3433-446B-A5BF-D70B3649CB6AQ33357230-1EC7ED83-AC87-439F-94BD-01372FD5C74EQ33499619-C0F0E961-D330-46FF-82AE-EBC4ADE8977DQ33840481-8A689213-7CCF-4E29-8C4A-4E2FD5C8143EQ33869054-857C3D49-5A04-481C-B03A-D2F3CDE41D4CQ34062545-58F65AD0-FA32-4965-9AD6-759004D70416Q34124223-9D420574-23C7-41D8-9323-C8B0F84D79A3Q34415448-89D85348-8A71-43BA-BDAA-1DD48BD294B6Q34795429-6865B531-9462-4DC1-A5E9-9ED8AEC682E7Q34812703-5B979FEB-F6F8-4668-A2B8-326025906B24Q34995501-AB008D1B-1FEC-4D64-B63A-0834D42D371FQ35071275-4B2350BB-8D35-46E7-A5D2-6CE541381215Q35078258-509817F7-78F8-4CA9-9D6C-E6F2AB1F6085Q35214311-21866BDC-C7EA-4588-9958-E0DDACEEF9D4Q35613320-C8ED9652-1391-4109-A1B4-E0FEB307856DQ35679338-449F1076-2882-4A49-98D4-18141D64BFE7Q35794379-66A573B1-3CF5-4A28-B109-3922DEEA9684Q35861493-7608C587-B447-4CD7-82AB-3977CDF270DFQ35866210-BDAB69BE-0FE0-452B-BD02-5A66041AF25AQ35940910-8A9C6E4B-A028-437D-8F53-B5F25A9BFA57Q36022460-EF96AA42-5303-4F24-BB3D-6E07F9BD758DQ36237770-A8D4CA67-A67F-4D53-8096-68257CCDE334Q36384024-47D1CF34-B5E2-4017-84E9-410B00636335Q36432281-BFA9C705-F99F-4EEB-BDA8-22BC2890EE5DQ36739752-157D8249-5A9A-4645-9320-42DFD5521E35Q36793788-F20094E3-213A-4029-B8A5-9635D2254208Q36965845-E25A10F7-9598-4F8E-B85E-253024165D71Q37054969-E177276B-9077-4B7C-9156-3E644CC1F18BQ37142625-A9C34964-0561-4B66-9A14-6B599AA68F66Q37298460-9848263A-B2DC-4AEB-BE45-EC1077AF3F8EQ37410310-E0A4CF16-057E-4CAB-8491-0782EE94B95DQ37566373-BDD94B3C-4B57-4746-B1FE-A18FC5E0982AQ38124703-8A4DE5E1-3068-49E7-AAC9-71D4EEBF70C7Q38192305-506D0383-0370-4F90-995D-142E053E6702Q38318669-AD7E0A51-3F10-4F72-A611-8939413EC3CA
P2860
Thrombospondin-1 is a major activator of TGF-beta in fibrotic renal disease in the rat in vivo.
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Thrombospondin-1 is a major ac ...... al disease in the rat in vivo.
@ast
Thrombospondin-1 is a major ac ...... al disease in the rat in vivo.
@en
type
label
Thrombospondin-1 is a major ac ...... al disease in the rat in vivo.
@ast
Thrombospondin-1 is a major ac ...... al disease in the rat in vivo.
@en
prefLabel
Thrombospondin-1 is a major ac ...... al disease in the rat in vivo.
@ast
Thrombospondin-1 is a major ac ...... al disease in the rat in vivo.
@en
P2093
P1433
P1476
Thrombospondin-1 is a major ac ...... nal disease in the rat in vivo
@en
P2093
Christian Hugo
Henry C Krutzsch
Joanne E Murphy-Ullrich
Julia Wiede
Solange M F Ribeiro
P304
P356
10.1111/J.1523-1755.2004.00395.X
P407
P577
2004-02-01T00:00:00Z
P5875
P6179
1031292525